AUROPHARMA - IntraDay Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

📈 Intraday Trade Analysis for AUROPHARMA

Trade Rating: 3.6

AUROPHARMA presents a mildly favorable setup for intraday trading, with technical indicators hinting at neutral-to-cautious optimism. Let’s dissect today’s potential.

⚙️ Technical & Price Action Signals

RSI (56.0): Neutral, but leaning bullish. Price strength is modest—not overheated.

MACD (-3.61): Slight bearish divergence, but flattening — watch for crossover.

Current Price (₹1,158): Hovering above 50-DMA (₹1,145) but below 200-DMA (₹1,185) — short-term support in place, yet resistance looms.

Volume Spike: Current volume (8.5L) > average (7.9L) shows active participation — bullish fuel.

🧾 Fundamental Pulse

Valuation: Stock P/E (19.5) well below industry average (34) — attractive pricing.

PEG Ratio (2.40): High, signals expensive relative to growth.

Profit Drop: QoQ PAT declined by 7.19% — dampens sentiment.

Institutional Activity: Mild DII buying (+0.70%) countered by FII selling (-0.95%) — sentiment mixed.

📌 Trade Strategy

🔍 If entering intraday today

Buy Range: ₹1,155 – ₹1,160 (enter near current price on dip or consolidation)

Profit Target: ₹1,180 – ₹1,185 (just under resistance at 200-DMA)

Stop Loss: ₹1,145 (below 50-DMA to limit downside risk)

🧭 If already holding intraday

Exit Conditions

Price approaches ₹1,180 with waning volume

RSI slips below 50 or MACD diverges deeper

Sudden sell-off near ₹1,150 with volume surge

Suggested Timeframe: Exit by 2:15 PM–2:45 PM IST if key levels are reached or no positive breakout emerges post-lunch session.

Would you like me to scan for other pharma stocks with stronger intraday momentum or back-test AUROPHARMA's typical intraday behavior based on recent sessions? Let's sharpen your edge in the market. 💼📊

Edit in a page